Clinical trial
Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX
NCT02517671 is registered in ClinicalTrials.gov with David Grant U.S. Air Force Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX
- Lead sponsor
- David Grant U.S. Air Force Medical Center
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- January 31, 2015
- Completion date
- October 7, 2017
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, pulmonary disease